Mechanisms of ErbB2-mediated paclitaxel resistance and trastuzumab-mediated paclitaxel sensitization in ErbB2-overexpressing breast cancers
Author:
- Dihua YuDYDihua Yu
- 1 October 2001
- journal article
- Published by Elsevier in Seminars in Oncology
- Vol. 28 (5N) , 12-17